Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

ClinicalTrials.gov ID: NCT03061305

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03061305. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 17, 2026, 8:18 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Many patients are treated for advanced cancer without knowledge of underlying molecular features that might indicate FDA approved therapies or potential eligibility for biomarker-selected clinical trials. The Strata Trial (STR-001-001) has been initiated by Strata Oncology to evaluate the clinical benefit of systematic comprehensive genomic profiling for participants with advanced cancer using real-world data and endpoints, while assessing the proportion of participants available for clinical trials and approved targeted therapies in advanced and/or aggressive cancers. The Strata Trial uses surplus, or leftover, tumor specimens for molecular profiling and does not require additional study-specific procedures.

Study identification

NCT ID
NCT03061305
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Strata Oncology
Industry
Enrollment
58,213 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2016 (Actual)
Primary completion
Jun 27, 2024 (Actual)
Completion
Jun 27, 2024 (Actual)
Last update posted
Jan 31, 2025

2016 – 2024

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
University of Alabama, Birmingham Birmingham Alabama 35294 —
Kaiser Permanente - Southern California Pasadena California 91101 —
Kaiser Permanente - Northern California Vallejo California 94589 —
SCL Health Broomfield Colorado 80021 —
Kaiser Permanente Colorado Denver Colorado 80218 —
Christiana Care Health System Newark Delaware 19713 —
SwedishAmerican Rockford Illinois 61114 —
Baptist Health Lexington Kentucky 40503 —
Christus Health Lake Charles Louisiana 70605 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Kaiser Permanente - Mid-Atlantic Rockville Maryland 20852 —
Minnesota Oncology - Burnsville Burnsville Minnesota 55337 —
Minnesota Oncology - Coon Rapids Coon Rapids Minnesota 55433 —
Fairview Southdale Hospital Edina Minnesota 55435 —
Minnesota Oncology - Maplewood Cancer Center Maplewood Minnesota 55109 —
St. John's Hospital Maplewood Minnesota 55109 —
Metro-Minnesota Community Oncology Research Consortium Minneapolis Minnesota 55101 —
Regions Hospital Minneapolis Minnesota 55101 —
Minnesota Oncology - Minneapolis Minneapolis Minnesota 55404 —
North Memorial Health Care Robbinsdale Minnesota 55422 —
Park Nicollet Health Services Saint Louis Park Minnesota 55416 —
Minnesota Oncology - Edina Saint Louis Park Minnesota 55435 —
Minnesota Oncology - Woodbury Clinic Woodbury Minnesota 55125 —
North Mississippi Medical Center Tupelo Mississippi 38801 —
University of North Carolina, Chapel Hill Chapel Hill North Carolina 27514 —
Hayworth Cancer Center High Point North Carolina 27262 —
UNC REX Healthcare Raleigh North Carolina 27607 —
Kettering Health Network Kettering Ohio 45429 —
Kaiser Permanente Northwest Portland Oregon 97227 —
Lehigh Valley Health Network Allentown Pennsylvania 18103 —
Prisma Health Cancer Institute Greenville South Carolina 29605 —
Bon Secours St. Francis Greenville South Carolina 29607 —
UTHealth - Memorial Hemann Cancer Institute Houston Texas 77030 —
Bon Secours Midlothian Midlothian Virginia 23114 —
MultiCare Tacoma Washington 98405 —
Gundersen Health System La Crosse Wisconsin 54601 —
University of Wisconsin Madison Wisconsin 53792 —
Marshfield Clinic Marshfield Wisconsin 54449 —
Aurora Research Institute Milwaukee Wisconsin 53226 —
ProHealth Care Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03061305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2025 · Synced Nov 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.